Neither Eliquis (apixaban) nor Xarelto (rivaroxaban) is universally better. Both prevent blood clots effectively, and for stroke prevention and blood clot recurrence, outcomes are similar. Where they differ most is bleeding risk, dosing convenience, kidney dependence, and how they interact with food and other medications. Those differences can make one a clearly better fit depending on your body and your daily life.
Bleeding Risk Favors Eliquis Overall
The most consistent difference between these two drugs is bleeding. In older patients being treated for blood clots, major bleeding occurred at a rate of 4.4 per 100 patient-years on Xarelto compared to 3.3 on Eliquis. That translates to roughly a 46% higher adjusted risk of major bleeding with Xarelto during the initial treatment period. During longer-term use beyond six months, that gap narrows and becomes statistically insignificant, with rates of 1.4 versus 1.2 per 100 patient-years.
The pattern holds in a five-year analysis from the RENOVE trial. At full doses, clinically relevant bleeding over five years was 14.4% with Xarelto and 16.5% with Eliquis, with no meaningful statistical difference. Major bleeding was 3.5% versus 4.6%. At reduced doses for extended treatment, both drugs showed similar safety profiles. The takeaway: during the first months of treatment, Xarelto carries a higher bleeding risk, but over the long term the two drugs converge.
GI Bleeding Is More Common With Xarelto
Gastrointestinal bleeding deserves its own mention because it’s the type of bleeding that most often affects daily quality of life. Across multiple large studies, Eliquis consistently comes out ahead. In a study of 50,000 patients with blood clots, GI bleeding occurred at a rate of 7.2 per 100 patient-years with Eliquis versus 10.6 with Xarelto, a 40% lower risk. A pooled analysis of eight retrospective studies found a similar pattern, with Eliquis carrying about 43% lower odds of GI bleeding. Another cohort study put the numbers at 2.5 versus 3.2 events per 100 person-years for overall GI bleeds, and 1.4 versus 1.9 for major GI bleeds.
If you have a history of stomach ulcers, gastritis, or other GI issues, this difference is clinically meaningful and often tips the decision toward Eliquis.
Stroke and Clot Prevention Are Similar
For the thing these drugs are primarily prescribed to do, preventing strokes in atrial fibrillation and stopping blood clots from coming back, there is no definitive winner. A large instrumental variable analysis published in Circulation found no significant difference in stroke, heart attack, or death rates between patients prescribed one drug versus the other. In the RENOVE trial’s five-year data for blood clot patients, recurrence rates were nearly identical: 2.0% with Eliquis versus 1.7% with Xarelto at full doses, and 1.4% versus 2.7% at reduced doses, with neither difference reaching statistical significance.
Once Daily vs. Twice Daily
Xarelto is taken once a day. Eliquis is taken twice a day. This sounds like a small difference, but it shows up clearly in adherence data. In a study of over 14,000 patients, 85.3% of Xarelto users maintained adequate adherence at 90 days compared to 79.9% of Eliquis users. At six months, the gap persisted: 75.8% versus 72.2%. Xarelto users were also less likely to have gaps of five or more days without medication.
Missing doses of a blood thinner can leave you unprotected. If you already struggle to remember a twice-daily medication, Xarelto’s simpler schedule is a real advantage. On the other hand, if you miss a single dose of Eliquis, you still have some drug in your system from the morning or evening dose. Missing your one daily Xarelto dose means a full day without protection.
Food Requirements Matter
Eliquis can be taken with or without food. Its absorption doesn’t meaningfully change either way.
Xarelto is different. At the standard 20 mg dose, taking it with food increases absorption by about 39% compared to taking it on an empty stomach. This means Xarelto at 15 mg or 20 mg must be taken with a meal to work properly. If you take it without food, you may not absorb enough of the drug to stay protected. The 10 mg dose doesn’t have this issue. For people with irregular eating habits or those who skip meals, this requirement can be a practical disadvantage.
Kidney Function Plays a Role
Both drugs are partially cleared through the kidneys, but the degree differs significantly. Only about 27% of Eliquis is eliminated by the kidneys, compared to 35% for Xarelto. This makes Eliquis the more commonly preferred option for people with reduced kidney function. With less reliance on the kidneys for drug clearance, Eliquis levels remain more predictable as kidney function declines. Xarelto can still be used in mild to moderate kidney disease, but the margin of safety is narrower.
Drug Interactions
Both Eliquis and Xarelto are broken down through the same liver pathways and transport systems, which means they share many of the same problematic drug interactions. Certain seizure medications (carbamazepine, phenytoin), the antibiotic rifampin, and the HIV drug ritonavir should be avoided with either drug.
Where they differ is flexibility. When interacting medications can’t be avoided, Eliquis often allows a dose reduction as a workaround. For example, certain antifungal medications like ketoconazole and itraconazole require avoiding Xarelto entirely, but with Eliquis, the dose can sometimes be cut in half instead. This gives prescribers more room to manage complex medication regimens, which is particularly relevant for people taking multiple drugs for cancer, HIV, or fungal infections.
How to Think About the Choice
The data points toward Eliquis as the safer option for most people, particularly regarding bleeding. It’s gentler on the GI tract, less dependent on kidney function, and more flexible when drug interactions arise. Xarelto’s advantages are practical: once-daily dosing leads to better adherence, and for patients on long-term extended treatment beyond six months, its safety profile essentially matches Eliquis.
Your prescriber will weigh your specific situation, including your kidney function, other medications, bleeding history, and how confident they are that you’ll stick with a twice-daily schedule. Neither drug is wrong. Both are effective, well-studied blood thinners that have largely replaced warfarin for good reason. The “better” choice is the one that fits your health profile and your daily routine well enough that you actually take it consistently.